Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 9,566 | 8,893 | 13,808 | 10,167 | 12,648 |
| Gross Profit | 9,566 | 8,893 | 13,808 | 10,167 | 12,648 |
| Operating Expenses | 35,952 | 33,331 | 32,275 | 29,609 | 30,598 |
| Operating Income | -26,386 | -24,438 | -18,467 | -19,442 | -17,950 |
| Interest Expense | 675 | 670 | 694 | 694 | 695 |
| Other Income | 7,027 | 7,158 | -5,455 | 6,025 | 5,054 |
| Pre-tax Income | -20,034 | -17,950 | -24,616 | -14,111 | -13,591 |
| Net Income Continuous | -20,034 | -17,950 | -24,616 | -14,111 | -13,591 |
| Net Income | $-20,034 | $-17,950 | $-24,616 | $-14,111 | $-13,591 |
| EPS Basic Total Ops | -1.05 | -0.91 | -0.28 | -0.98 | -1.19 |
| EPS Basic Continuous Ops | -1.02 | -0.92 | -1.15 | -0.95 | -1.20 |
| EPS Diluted Total Ops | -1.05 | -0.91 | -0.28 | -0.98 | -1.19 |
| EPS Diluted Continuous Ops | -1.02 | -0.92 | -1.15 | -0.95 | -1.20 |
| EBITDA(a) | $-23,780 | $-21,845 | $-15,183 | $-17,219 | $-15,503 |